drugset

drugset / Trial / NCT00865176

Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions

NCT00865176 ↗

Phase 1 Completed 60 enrolled Sandoz

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to demonstrate the relative bioequivalence of Eplerenone 50 mg ER Tablets under fasting conditions.

Timeline

Start: 2006-06
Primary completion: 2006-07
Completion: 2006-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Eplerenone	Unknown	50 mg	—

Indications